New York, NY, United States of America

Samuel C Silverstein

USPTO Granted Patents = 10 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 103(Granted Patents)


Company Filing History:


Years Active: 1995-2021

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Samuel C. Silverstein

Introduction

Samuel C. Silverstein is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of immunotherapy, particularly in methods for treating infectious and neoplastic diseases. With a total of 10 patents to his name, Silverstein's work has had a profound impact on medical science.

Latest Patents

Among his latest patents, Silverstein has developed methods for treating subjects suffering from infectious or neoplastic diseases using immunotherapy. One of the key aspects of his method involves determining the critical concentration of immune cells required to effectively treat or eradicate these diseases. This is achieved through an in vitro assay, which is a significant advancement in the field of immunotherapy. The method emphasizes the importance of administering the critical concentration of immune cells determined in the assay to the subject.

Career Highlights

Silverstein has had a distinguished career, with notable affiliations including Columbia University. His work at this prestigious institution has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include John D. Loike and Christina Kabbash. Their collaborative efforts have further enhanced the impact of Silverstein's innovations in immunotherapy.

Conclusion

Samuel C. Silverstein's contributions to the field of immunotherapy are invaluable. His innovative methods for treating infectious and neoplastic diseases continue to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…